2023中国阿尔茨海默病数据与防控策略  

2023 Data and Strategies of Prevention and Control for Alzheimer’s Disease in China

作　　者：徐勇[1] 王军[2] 王虹峥[3] 王延江 刘肇瑞[5] 郁金泰 周知[7] 彭丹涛[7] 顾栢俊 李坤成[9] 侯清华[10] 马辛[11] 王晓明[12] 王志稳[13] 王惠芳[14] 汤彬 Yong XU;Jun WANG;Hongzheng WANG;Yanjiang WANG;Zhaorui LIU;Jintai YU;Zhi ZHOU;Dantao PENG;BaijunGU;Kuncheng LI;Qinghua HOU;Xin MA;Xiaoming WANG;Zhiwen WANG;Huifang WANG;Bin TANG

机构地区：[1]苏州大学卫生发展研究中心,江苏215006 [2]北京交通大学生命科学与生物工程研究院,北京100044 [3]北京协和医学院,北京100005 [4]陆军特色医学中心(大坪医院),重庆400042 [5]北京大学第六医院,北京100191 [6]复旦大学附属华山医院,贵州550001 [7]中日友好医院神经科,北京100029 [8]澳大利亚墨尔本大学Florey研究所,澳大利亚3010 [9]首都医科大学宣武医院,北京100053 [10]中山大学附属第七医院神经医学中心,广东深圳光明518107 [11]首都医科大学附属北京安定医院,北京100032 [12]川北医学院附属医院,四川637002 [13]北京大学护理学院,北京100191 [14]同济大学附属养志康复医院(上海市阳光康复中心),上海201613 [15]上海剪爱公益发展中心,上海200030

出　　处：《阿尔茨海默病及相关病杂志》2023年第3期175-192,共18页Chinese Journal of Alzheimer's Disease and Related Disorders

摘　　要：本报告汇总了阿尔茨海默病及痴呆相关领域现有的最新数据,分析了我国阿尔茨海默病的流行病学、疾病负担、诊断治疗、风险因素、康复护理和疾病筛查等各方面的现状、问题以及趋势,针对目前中国民众和政策制定者最关心的问题,例如:阿尔茨海默病基本数据是怎样的?为什么知晓率相对提高,但是患者就诊愿望相对不高?如何采用有效的措施来应对,等等,提出了目前阿尔茨海默病的防控策略。特别强调了要大力开发经过验证的早期筛查和诊断工具,提供更有效治疗的创新药物,以及鼓励和建立全国性属地化社会互助支持网络。本报告期望能对医学专业人士、患者、家属和照护者、政府政策制定人员、养老机构等有所帮助,能为阿尔茨海默病的防治工作提供支撑,为相关卫生政策的制定提供依据和建议,有助于提高公众对阿尔茨海默病的认识,以期缓解我国阿尔茨海默病疾病的整体负担,推动我国健康老龄化的实现。According to the National Bureau of Statistics of China in 2023,the population aged>60 in China is about 280 million,accounting for approximately 19.84%of the total population.Among them,the population aged>65 is about 210 million,accounting for approximately 14.86%of the total population.China has rapidly entered a deep aging society.The aging population has also brought about a rapid increase in age-related disabilities and diseases,bringing a heavy burden to society and families.Among them,Alzheimer's disease(AD)is the most common type of dementia in the elderly and one of the most common causes of loss of daily living abilities in the elderly.There are currently about 9.83 million AD patients in China,with a severe disease burden,which brings heavy medical,care,and economic burdens to families and society.It has become one of the most expensive,deadly,and burdensome diseases in current healthcare,seriously affecting public health and sustainable social development in China.However,the diagnostic and treatment rates of AD in China are still relatively low.Therefore,strengthening the prevention and treatment of AD,preventing and slowing down the occurrence and development of AD are urgent public health issues.This report is aimed at the most concerned issues of people and government agency,such as:What is the current basic data on Alzheimer's disease in China?Why is the awareness rate relatively increased but the patient's desire to seek medical treatment relatively low?Are there any effective measures to address this?This report summarizes the latest data available in various related fields,analyzes the current situation,problems,and trends of AD epidemiology,disease burden,diagnosis and treatment,risk factors,rehabilitation care,and disease screening in China,and proposes China's Alzheimer's disease prevention and control strategies,especially emphasized the importance of development of validated tools for screening and early diagnosis,the innovation of new drugs,and building and cultivating a nationwide netw

关 键 词：中国阿尔茨海默病数据 老龄化 老年痴呆 诊断与治疗 防控 策略 社会支持 

分 类 号：R749[医药卫生—神经病学与精神病学]